Skip to content
← Full study record

NCT03836209 · MORE INFO

Limitations, agreements, and source contact

Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia · Source last updated 2026-07-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
Li Chen <lic@ds.dfci.harvard.edu>
organization
PrECOG
phone
857-284-3670
title
Li Chen, MS; Statistician
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
Li Chen <lic@ds.dfci.harvard.edu>
organization
PrECOG
phone
857-284-3670
title
Li Chen, MS; Statistician

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice